<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <article-meta>
      <title-group>
        <article-title>Spectrophotometric method development and validation for the estimation of ticagrelor in bulk and its dosage forms</article-title>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="person">
          <name>
            <given-names>A. Ajitha </given-names>
          </name>
          <email>ajithaazhakesan27@gmail.com</email>
          <xref ref-type="aff" rid="aff-1"/>
        </contrib>
      </contrib-group>
      <aff id="aff-1">
        <institution>Dept of Pharmaceutical Analysis and Quality Assurance, CMR College of Pharmacy, Medchal, Hyderabad, India-501401</institution>
        <country>India</country>
      </aff>
      <history>
        <date date-type="received" iso-8601-date="2020-08-11">
          <day>11</day>
          <month>08</month>
          <year>2020</year>
        </date>
        <date data-type="published" iso-8601-date="2020-08-11">
          <day>11</day>
          <month>08</month>
          <year>2020</year>
        </date>
      </history>
    </article-meta>
  </front>
  <body>
    <fig>
      <graphic mimetype="image" mime-subtype="jpeg" xlink:href="image1.jpeg"/>
    </fig>
    <p>
      <bold>www.ijamscr.com</bold>
    </p>
    <sec id="sec-1">
      <title>Spectrophotometric method development and validation for the estimation of ticagrelor in bulk and its dosage forms</title>
      <sec id="sec-1_1">
        <title>P. Sireesha<sup>*1</sup>, A. Ajitha<sup>2</sup>, T. Rama Mohan Reddy<sup>3</sup></title>
        <p>
          <italic>
            <sup>*1</sup>
          </italic>
          <italic>(</italic>
          <italic>Dept</italic>
          <italic> of Pharmaceutical Analysis and Quality Assurance, CMR College </italic>
          <italic>of </italic>
          <italic>Pharmacy, </italic>
          <italic>Medchal</italic>
          <italic>, Hyderabad, India-501401.) </italic>
        </p>
        <p>
          <italic>
            <sup>2</sup>
          </italic>
          <italic>(</italic>
          <italic>Dept</italic>
          <italic> of Pharmaceutical Analysis and Quality Assurance, CMR College </italic>
          <italic>of </italic>
          <italic>Pharmacy, </italic>
          <italic>Medchal</italic>
          <italic>, Hyderabad, India-501401.)</italic>
          <italic>.</italic>
        </p>
        <p>
          <italic>
            <sup>3</sup>
          </italic>
          <italic>Associate Professor, department of Pharmaceutical Chemistry, CMR College of Pharmacy, </italic>
          <italic>Medchal</italic>
          <italic>, Hyderabad-501401.</italic>
        </p>
        <p><bold>*Corresponding Author</bold>: <bold>A. </bold><bold>Ajitha</bold></p>
        <p>
          <bold>Email id: </bold>
          <bold>ajithaazhakesan27@gmail.com</bold>
        </p>
        <sec id="sec-1_1_1">
          <title>Abstract</title>
          <p>Simple, sensitive, accurate, precise, stability indicating   UV   spectrophotometric method have been developed   for quantitative determination of ticagrelor in bulk and its dosage form. The UV spectrum was scanned between 200-400 nm and 254 nm was selected as maximum wavelength for absorption. Beer’s law was obeyed in the concentration range of   2-10µg/ml were found the method was successfully applied to the pharmaceutical dosage forms containing the above mentioned drug without any interference by excipients. Results of the analysis were validated as per ICH guidelines. This method can be used for the routine and quality control analysis of ticagrelor in raw material and pharmaceutical formulations.</p>
          <p>Keywords:Ticagrelor, UV Spectrophotometric method, Validation.</p>
        </sec>
        <sec id="sec-1_1_2"/>
        <sec id="sec-1_1_3">
          <title>INTRODUCTION</title>
          <p>The scope of developing and validating analytical method is to ensure a suitable method for a particular analyte more specific accurate and precise<sup>1</sup>. The main objective for that is to improve the conditions and parameters, which should be followed in the development and validation.Ticagrelor is an   anticoagulant and anti platelet drug it blocks adenosine diphosphate (ADP) receptors of sub type P2Y12.Ticagrelor is chemically (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-D)pyrimidine-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol. Literature review revels that Ticagrelor lower the risk of thrombotic cardiovascular events in patients suffering from coronary syndrome<sup>1</sup>. UV spctrophotometric method is best analytical method for the determination of Ticagrelor<sup>1</sup>.Extensive survey revealed that number of methods has been reported for estimation of Ticagrelor<sup>2</sup>. The aim of the present work is to develop a new simple rapid reproducible, inexpensive and efficient linear spectrophotometric method for the estimation of ticagrelorin bulk and its tablet dosage forms.</p>
          <fig>
            <graphic mimetype="image" mime-subtype="jpeg" xlink:href="image2.jpeg"/>
          </fig>
          <p>
            <bold>Fig 1: Chemical structure of </bold>
            <bold>Ticagrelor</bold>
          </p>
        </sec>
        <sec id="sec-1_1_4"/>
        <sec id="sec-1_1_5">
          <title>MATERIALS AND METHODS</title>
          <p>Ticagrelor dosage form provide AstraZenecapharma India Ltd.(Label claim 90mg) GR Grade acetonitrile and LR Grade Methanol were procured from  SD Fine chem Ltd. Water, Whatmann Filter paper.</p>
          <sec id="sec-1_1_5_1">
            <title>Apparatus</title>
            <p>Weighing balance, UV- Visible Spectrophotometer, (Spectral and absorbance measurements were made on a UV- Visible spectrophotometer with 10mm, Matched pair of quartz cell and spectral band width of ± 2nm.) Volumetric flask, Pipette, Sonicator, Hot air oven.</p>
          </sec>
          <sec id="sec-1_1_5_2">
            <title>UV Method Development </title>
          </sec>
          <sec id="sec-1_1_5_3">
            <title>Preparation of Ticagrelor standard stock solution</title>
            <p>Stock solution (10µg/ml) of Ticagrelor sample was prepared by transferring 10 mg, accurately weighed, into a 10 ml volumetric flask and adding 5 ml acetonitrile .The solution was sonicated for 2 min to dissolve Ticagrelor and the solution was then diluted to volume with the same solvent. Further pipette out 1 ml of this solution and dilute up to 10 ml with acetonitrile .(100µg/ml). Further pipette out 2.5 ml of this solution and dilute up to 25 ml with acetonitrile. (10µg/ml).</p>
          </sec>
          <sec id="sec-1_1_5_4">
            <title>Preparation of Calibration curve</title>
            <p>Calibration curve was constructed in accordance with optimum conditions. Aliquot of standard Ticagrelor solution (100µg/ml) was transferred into volumetric flask. At respect concentration (2 µg/ml, 4 µg/ml, 6µg/ml, 8µg/ml and 10µg/ml) and the absorbance was measured at 254nm.The solution we scanned in the range of 200-400nm against Acetonitrile as blank. A calibration cure was plotted against Absorbance and concentration. The optical characteristics are summarized in Table no 1.</p>
            <p>
              <bold>Table no: 1 Calibration curve</bold>
            </p>
            <table-wrap>
              <table>
                <tr>
                  <td>
                    <bold>S.no</bold>
                  </td>
                  <td>
                    <bold>Concentration( µg/ml)</bold>
                  </td>
                  <td>
                    <bold>Absorbance(nm)</bold>
                  </td>
                </tr>
                <tr>
                  <td>1.</td>
                  <td>2</td>
                  <td>0.097</td>
                </tr>
                <tr>
                  <td>2.</td>
                  <td>4</td>
                  <td>0.165</td>
                </tr>
                <tr>
                  <td>3.</td>
                  <td>6</td>
                  <td>0.23</td>
                </tr>
                <tr>
                  <td>4.</td>
                  <td>8</td>
                  <td>0.298</td>
                </tr>
                <tr>
                  <td>5.</td>
                  <td>10</td>
                  <td>0.370</td>
                </tr>
              </table>
            </table-wrap>
            <fig>
              <graphic mimetype="image" mime-subtype="png" xlink:href="image3.png"/>
            </fig>
            <p>
              <bold>Fig: 2 Determination of </bold>
              <bold>λmax</bold>
              <bold> of </bold>
              <bold>Ticagrelor</bold>
              <bold> by UV spectrophotometer</bold>
            </p>
          </sec>
          <sec id="sec-1_1_5_5"/>
          <sec id="sec-1_1_5_6"/>
          <sec id="sec-1_1_5_7">
            <title>Assay of Ticagrelor in Dosage Forms</title>
            <p>Ten tablets were taken and powered. Weigh a quantity equivalent to 90mg of ticagrelor and transferred into 100ml volumetric flask and dissolve in a small quantity of acetonitrile. The Solution was sonicated and followed by filtration. The first few ml was discarded and the resulting solution is further diluted to produce required concentration. The absorbance was measured at 254nm using Acetonitrile  as blank. The maximum absorbance of sample was found to be 0.21 at 254nm.</p>
          </sec>
          <sec id="sec-1_1_5_8">
            <title>UV- method validation</title>
          </sec>
          <sec id="sec-1_1_5_9">
            <title>Accuracy</title>
            <p>Accuracy should be reported as percent recovery by the assay of known added amount of analyte in the sample or as the difference between the mean and the accepted true value, together with the confidence intervals.</p>
            <p>
              <bold>Table no: 2 Accuracy of </bold>
              <bold>Ticagrelor</bold>
            </p>
            <table-wrap>
              <table>
                <tr>
                  <td>
                    <bold>Brand name</bold>
                  </td>
                  <td>
                    <bold>Label claim</bold>
                  </td>
                  <td>
                    <bold>Amount of drug estimated</bold>
                  </td>
                  <td>
                    <bold>%label claim</bold>
                  </td>
                  <td>
                    <bold>Standard deviation</bold>
                  </td>
                </tr>
                <tr>
                  <td>Ticagrelor</td>
                  <td>90mg</td>
                  <td>89.3</td>
                  <td>99.2%</td>
                  <td>.102</td>
                </tr>
              </table>
            </table-wrap>
          </sec>
          <sec id="sec-1_1_5_10"/>
          <sec id="sec-1_1_5_11">
            <title>Precision</title>
            <p>The degree of agreement between an individual test result when the procedure is applied repeatedly to multiple samplings. it is expressed as relative standard deviation.</p>
            <p>The reproducibility of the proposed method were determined by performing the tablet assay at different intervals of same day (intra -day) and three different days (inter day).the result of intra- day and inter-day was expressed in %RSD. Here the study of precision was analysed by measuring the same concentration 6µg/ml in six replicate readings.</p>
            <p>
              <bold>Table no: 3 </bold>
              <bold>Intraday</bold>
              <bold> precision</bold>
            </p>
            <table-wrap>
              <table>
                <tr>
                  <td>
                    <bold>Concentration(µg/ml)</bold>
                  </td>
                  <td>
                    <bold>Absorbance 1</bold>
                  </td>
                  <td>
                    <bold>Absorbance 2</bold>
                  </td>
                  <td>
                    <bold>Absorbance 3</bold>
                  </td>
                </tr>
                <tr>
                  <td>6µg/ml</td>
                  <td>0.230</td>
                  <td>0.234</td>
                  <td>0.232</td>
                </tr>
                <tr>
                  <td>6µg/ml</td>
                  <td>0.232</td>
                  <td>0.234</td>
                  <td>0.230</td>
                </tr>
                <tr>
                  <td>6µg/ml</td>
                  <td>0.234</td>
                  <td>0.231</td>
                  <td>0.230</td>
                </tr>
                <tr>
                  <td>6µg/ml</td>
                  <td>0.231</td>
                  <td>0.230</td>
                  <td>0.233</td>
                </tr>
                <tr>
                  <td>6µg/ml</td>
                  <td>0.230</td>
                  <td>0.234</td>
                  <td>0.234</td>
                </tr>
                <tr>
                  <td>6µg/ml</td>
                  <td>0.234</td>
                  <td>0.234</td>
                  <td>0.232</td>
                </tr>
                <tr>
                  <td>%RSD</td>
                  <td>0.78</td>
                  <td>0.79</td>
                  <td>0.69</td>
                </tr>
                <tr>
                  <td>Average% RSD</td>
                  <td colspan="3">                             0.75</td>
                </tr>
              </table>
            </table-wrap>
            <p>
              <bold>Table no: 4 Inter day precision</bold>
            </p>
            <table-wrap>
              <table>
                <tr>
                  <td>
                    <bold>Concentration(µg/ml)</bold>
                  </td>
                  <td>
                    <bold>Absorbance 1</bold>
                  </td>
                  <td>
                    <bold>Absorbance 2</bold>
                  </td>
                  <td>
                    <bold>Absorbance 3</bold>
                  </td>
                </tr>
                <tr>
                  <td>6µg/ml</td>
                  <td>0.233</td>
                  <td>0.234</td>
                  <td>0.232</td>
                </tr>
                <tr>
                  <td>6µg/ml</td>
                  <td>0.230</td>
                  <td>0.232</td>
                  <td>0.237</td>
                </tr>
                <tr>
                  <td>6µg/ml</td>
                  <td>0.234</td>
                  <td>0.233</td>
                  <td>0.234</td>
                </tr>
                <tr>
                  <td>6µg/ml</td>
                  <td>0.232</td>
                  <td>0.234</td>
                  <td>0.235</td>
                </tr>
                <tr>
                  <td>6µg/ml</td>
                  <td>0.234</td>
                  <td>0.235</td>
                  <td>0.236</td>
                </tr>
                <tr>
                  <td>6µg/ml</td>
                  <td>0.232</td>
                  <td>0.234</td>
                  <td>0.234</td>
                </tr>
                <tr>
                  <td>%RSD</td>
                  <td>0.64</td>
                  <td>0.76</td>
                  <td>0.74</td>
                </tr>
                <tr>
                  <td>Average% RSD</td>
                  <td colspan="3">                                0.71</td>
                </tr>
              </table>
            </table-wrap>
          </sec>
          <sec id="sec-1_1_5_12"/>
          <sec id="sec-1_1_5_13"/>
          <sec id="sec-1_1_5_14">
            <title>Linearity</title>
            <p>The linearity of the response of the drug was verified at 2-10µg/ml concentration. The calibration graph was obtained by plotted the absorbance versus the concentration data and was treated by linear regression analysis..... The equation of the calibration curve for Ticagrelor obtained y =0.034x + 0.028 the calibration curve was found to be linear in the above mentioned concentrations. The correlation coefficient (r<sup>2</sup>) of determination was 0.999. </p>
            <p>
              <bold>Table for all parameters</bold>
            </p>
            <table-wrap>
              <table>
                <tr>
                  <td>
                    <bold>S.no</bold>
                  </td>
                  <td>
                    <bold>  Parameters</bold>
                  </td>
                  <td>
                    <bold>       Results</bold>
                  </td>
                </tr>
                <tr>
                  <td>1</td>
                  <td>Absorption maxima (nm)</td>
                  <td>254nm</td>
                </tr>
                <tr>
                  <td>2</td>
                  <td>Linearity range (µg/ml)</td>
                  <td>2-10</td>
                </tr>
                <tr>
                  <td>3</td>
                  <td>Standard regression equation </td>
                  <td>y =0.034x + 0.028</td>
                </tr>
                <tr>
                  <td>4</td>
                  <td>Correlation coefficient (r<sup>2</sup>)</td>
                  <td>0.999</td>
                </tr>
                <tr>
                  <td>5</td>
                  <td>Accuracy </td>
                  <td>102</td>
                </tr>
                <tr>
                  <td>6</td>
                  <td>Precision </td>
                  <td>0.75 (intraday)0.71 (inter day)</td>
                </tr>
              </table>
            </table-wrap>
          </sec>
        </sec>
        <sec id="sec-1_1_6">
          <title>References </title>
          <list list-type="bullet">
            <list-item>
              <p>M. A. Ambasana, N. P. Kapuriya, K. M. Mangantani, K. D. Ladva.An improved assay method for the estimation of ticagrelor HCL by RP-HPLC. International journal of pharmaceutical since. 2016. Vol 7.</p>
            </list-item>
            <list-item>
              <p>Introduction of ticagrlor by  National institute for health and excellence, Nice technology appraisal guidance, 2011, 236, 1</p>
            </list-item>
            <list-item>
              <p>L. Kalyani, A. LakshmanaRao, spectrophotometric method development and validation of estimation of ticagrelor in bulk and its dosage form Int. J. of Pharm., 2013, 3, 634.</p>
            </list-item>
            <list-item>
              <p>ICH Harmonised Tripartite Guideline. Q2(R1), Validation of Analytical Procedures: Text and  Methodology. International Conference on Harmonisation, 2005</p>
            </list-item>
            <list-item>
              <p>www.google.com</p>
            </list-item>
            <list-item>
              <p>www.drugs.com</p>
            </list-item>
            <list-item>
              <p>www.fda.gov</p>
            </list-item>
            <list-item>
              <p>www.mims.com/India</p>
            </list-item>
          </list>
        </sec>
        <sec id="sec-1_1_7"/>
      </sec>
    </sec>
  </body>
  <back/>
</article>
